| SARS-CoV-2–specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence G den Hartog, RM Schepp, M Kuijer, C GeurtsvanKessel, J van Beek, ... The Journal of infectious diseases 222 (9), 1452-1461, 2020 | 132 | 2020 |
| Detection of serum antibodies to bovine norovirus in veterinarians and the general population in the Netherlands MA Widdowson, B Rockx, R Schepp, WHM Van Der Poel, J Vinje, ... Journal of medical virology 76 (1), 119-128, 2005 | 105 | 2005 |
| Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave ERA Vos, G den Hartog, RM Schepp, P Kaaijk, J van Vliet, K Helm, ... J epidemiol community health 75 (6), 489-495, 2021 | 99 | 2021 |
| Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study G den Hartog, ERA Vos, LL van den Hoogen, M van Boven, RM Schepp, ... Clinical Infectious Diseases 73 (12), 2155-2162, 2021 | 96 | 2021 |
| Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses M Scherpenisse, RM Schepp, M Mollers, CJLM Meijer, GAM Berbers, ... PloS one 8 (9), e74797, 2013 | 94 | 2013 |
| Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine RM de Voer, L Mollema, RM Schepp, SC de Greeff, PGM van Gageldonk, ... PloS one 5 (8), e12144, 2010 | 94 | 2010 |
| Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study MW Heijstek, M Scherpenisse, N Groot, C Tacke, RM Schepp, ... Annals of the rheumatic diseases 73 (8), 1500-1507, 2014 | 86 | 2014 |
| Seroprevalence of seven high-risk HPV types in The Netherlands M Scherpenisse, M Mollers, RM Schepp, HJ Boot, HE de Melker, ... Vaccine 30 (47), 6686-6693, 2012 | 60 | 2012 |
| Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination M Scherpenisse, M Mollers, RM Schepp, CJLM Meijer, HE de Melker, ... Human vaccines & immunotherapeutics 9 (2), 314-321, 2013 | 56 | 2013 |
| Simultaneous Detection of Haemophilus influenzae Type b Polysaccharide-Specific Antibodies and Neisseria meningitidis Serogroup A, C, Y, and W-135 … RM de Voer, RM Schepp, FGA Versteegh, FRM van der Klis, ... Clinical and Vaccine Immunology 16 (3), 433-436, 2009 | 53 | 2009 |
| Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016 GS Freidl, A Tostmann, M Curvers, WLM Ruijs, G Smits, R Schepp, ... Vaccine 36 (12), 1664-1672, 2018 | 51 | 2018 |
| Seroepidemiology of high-risk HPV in HIV-negative and HIV-infected MSM: the H2M study SH Mooij, FRM van der Klis, MAB van der Sande, RM Schepp, ... Cancer epidemiology, biomarkers & prevention 22 (10), 1698-1708, 2013 | 49 | 2013 |
| Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly AM Buisman, F Abbink, RM Schepp, JAJ Sonsma, T Herremans, ... The Journal of infectious diseases 197 (5), 698-706, 2008 | 38 | 2008 |
| Population-based serology reveals risk factors for RSV infection in children younger than 5 years SP Andeweg, RM Schepp, J van de Kassteele, L Mollema, GAM Berbers, ... Scientific reports 11 (1), 8953, 2021 | 37 | 2021 |
| Decline of RSV-specific antibodies during the COVID-19 pandemic G den Hartog, PB van Kasteren, RM Schepp, AC Teirlinck, ... The Lancet Infectious Diseases 23 (1), 23-25, 2023 | 36 | 2023 |
| Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide … RM De Voer, FRM Van der Klis, CWAM Engels, RM Schepp, ... Vaccine 27 (50), 6974-6982, 2009 | 35 | 2009 |
| The role of peptide loops of the Bordetella pertussis protein P. 69 pertactin in antibody recognition M Hijnen, R de Voer, FR Mooi, R Schepp, EE Moret, P van Gageldonk, ... Vaccine 25 (31), 5902-5914, 2007 | 33 | 2007 |
| Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation EA van Erp, AJ Lakerveld, E de Graaf, MD Larsen, RM Schepp, ... Clinical & translational immunology 9 (2), e1112, 2020 | 32 | 2020 |
| Comparison of different assays to assess human papillomavirus (HPV) type 16-and 18-specific antibodies after HPV infection and vaccination M Scherpenisse, RM Schepp, M Mollers, SH Mooij, CJLM Meijer, ... Clinical and Vaccine Immunology 20 (8), 1329-1332, 2013 | 32 | 2013 |
| Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses HJ Boot, RM Schepp, FJHB van Nunen, TG Kimman Journal of virological methods 116 (1), 35-43, 2004 | 31 | 2004 |
